Back
Safety Insurance Group Vs. Avidity Biosciences Industry Stock Comparison
Sell
46
SAFT
Safety Insurance Group
Last Price:
86.71
Seasonality Move:
3.23%
Sell
42
RNA
Avidity Biosciences
Last Price:
46.75
Seasonality Move:
39.98%
Sell
46
Safety Insurance Group (SAFT)
is a Sell
Is Safety Insurance Group a Buy, Sell or Hold?
- The current Safety Insurance Group [SAFT] share price is $87.24. The Score for SAFT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- SAFT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $47.13. The Score for RNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAFT Stock Price Chart
What is Safety Insurance Group's stock price today?
-
The Safety Insurance Group share price today is $87.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAFT is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $47.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight selling pressure.
SAFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 65.25 | Buy |
| Chaikin Money Flow: | -33976 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.38 - 84.12) | Buy |
| Bollinger Bands (100): | (77.93 - 85.05) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 55.24 | Buy |
| Chaikin Money Flow: | -248351 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.93 - 47.71) | Buy |
| Bollinger Bands (100): | (41.2 - 46.58) | Buy |
SAFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.71 | Buy |
| 20-day SMA: | 81.51 | Buy |
| 50-day SMA: | 81.95 | Buy |
| 200-day SMA: | 80.98 | Buy |
| 8-day EMA: | 83.98 | Buy |
| 20-day EMA: | 82.22 | Buy |
| 50-day EMA: | 81.8 | Buy |
| 200-day EMA: | 80.43 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.33 | Buy |
| 20-day SMA: | 45.94 | Buy |
| 50-day SMA: | 44.62 | Buy |
| 200-day SMA: | 33.49 | Buy |
| 8-day EMA: | 46.11 | Buy |
| 20-day EMA: | 45.68 | Buy |
| 50-day EMA: | 44.8 | Buy |
| 200-day EMA: | 35.08 | Buy |
Safety Insurance Group Earnings Growth & SAFT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.
Safety Insurance Group Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||